Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Jabir MS, Saad HM, Batiha GE-S (2023) NF-κB/NLRP3 inflammasome axis and risk of parkinson’s disease in type 2 diabetes mellitus: a narrative review and new perspective. J Cell Mol Med 27:1775–1789. https://doi.org/10.1111/jcmm.17784

Article  CAS  PubMed  PubMed Central  Google Scholar 

Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323:548–560. https://doi.org/10.1001/jama.2019.22360

Article  PubMed  Google Scholar 

Atawodi SE, Mende P, Pfundstein B, Preussmann R, Spiegelhalder B (1995) Nitrosatable amines and nitrosamide formation in natural stimulants: Cola acuminata, C. nitida and Garcinia cola. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc 33:625–630. https://doi.org/10.1016/0278-6915(95)00035-z

Article  CAS  Google Scholar 

Bayala B, Zouré AA, Zohoncon TM, Tinguerie BL, Baron S, Bakri Y, Simpore J, Lobaccaro J-MA (2020) Effects of extracts and molecules derived from medicinal plants of West Africa in the prevention and treatment of gynecological cancers. Rev Am J Cancer Res 10:2730–2741

CAS  Google Scholar 

Bernard K, Mota JA, Wene P, Corenblum MJ, Saez JL, Bartlett MJ, Heien ML, Doyle KP, Polt R, Hay M, Madhavan L, Falk T (2024) The angiotensin (1–7) glycopeptide PNA5 improves cognition in a chronic progressive mouse model of parkinson’s disease through modulation of neuroinflammation. Exp Neurol 381:114926. https://doi.org/10.1016/j.expneurol.2024.114926

Article  CAS  PubMed  Google Scholar 

Braatz C, Komes MP, Ravichandran KA, de Fragas MG, Griep A, Schwartz S, McManus RM, Heneka MT (2024) NLRP3-directed antisense oligonucleotides reduce microglial immunoactivities in vitro. J Neurochem 168:3467–3481. https://doi.org/10.1111/jnc.15778

Article  CAS  PubMed  Google Scholar 

Chen J, Chen Y-Q, Shi Y-J, Ding S-Q, Shen L, Wang R, Wang Q-Y, Zha C, Ding H, Hu J-G, Lü H-Z (2021) VX-765 reduces neuroinflammation after spinal cord injury in mice. Neural Regen Res 16:1836–1847. https://doi.org/10.4103/1673-5374.306096

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dewole EA, Dewumi DFA, Alabi JYT, Adegoke A (2013) Proximate and phytochemical of Cola nitida and Cola acuminata. Pak J Biol Sci PJBS 16:1593–1596. https://doi.org/10.3923/pjbs.2013.1593.1596

Article  CAS  PubMed  Google Scholar 

Duarte-Jurado AP, Gopar-Cuevas Y, Saucedo-Cardenas O, Loera-Arias MdeJ, Montes-de-Oca-Luna R, Garcia-Garcia A, Rodriguez-Rocha H (2021) Antioxidant therapeutics in Parkinson’s disease: current challenges and opportunities. Antioxid Basel Switz 10:453. https://doi.org/10.3390/antiox10030453

Article  CAS  Google Scholar 

Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K, Parkinson Study Group (2004) Levodopa and the progression of Parkinson’s disease. N Engl J Med 351:2498–2508. https://doi.org/10.1056/NEJMoa033447

Article  CAS  PubMed  Google Scholar 

Fan Z, Liang Z, Yang H, Pan Y, Zheng Y, Wang X (2017) Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia. J Neuroinflammation 14:256. https://doi.org/10.1186/s12974-017-1036-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng J, Wang J-X, Du Y-H, Liu Y, Zhang W, Chen J-F, Liu Y-J, Zheng M, Wang K-J, He G-Q (2018) Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 Transgenic mice. CNS Neurosci Ther 24:1207–1218. https://doi.org/10.1111/cns.12983

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, Robertson AAB, Butler MS, Rowe DB, O’Neill LA, Kanthasamy AG, Schroder K, Cooper MA, Woodruff TM (2018) Inflammasome Inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med 10:eaah4066. https://doi.org/10.1126/scitranslmed.aah4066

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grotemeyer A, Fischer JF, Koprich JB, Brotchie JM, Blum R, Volkmann J, Ip CW (2023) Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson’s disease. J Neuroinflammation 20:79. https://doi.org/10.1186/s12974-023-02759-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

He H, Jiang H, Chen Y, Ye J, Wang A, Wang C, Liu Q, Liang G, Deng X, Jiang W, Zhou R (2018) Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun 9:2550. https://doi.org/10.1038/s41467-018-04947-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14:388–405. https://doi.org/10.1016/S1474-4422(15)70016-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu C, Ding H, Li Y, Pearson JA, Zhang X, Flavell RA, Wong FS, Wen L (2015) NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets. Proc Natl Acad Sci U S A 112:11318–11323. https://doi.org/10.1073/pnas.1513509112

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ishola IO, Oloyo AK, Olubodun-Obadun TG, Godswill OD, Omilabu SA, Adeyemi OO (2023) Neuroprotective potential of plant derived parenchymal stem cells extract on environmental and genetic models of Parkinson disease through Attenuation of oxidative stress and neuroinflammation. Metab Brain Dis 38:557–571. https://doi.org/10.1007/s11011-022-01120-3

Article  CAS  PubMed  Google Scholar 

Jankovic J, Tan EK (2020) Parkinson’s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91:795–808. https://doi.org/10.1136/jnnp-2019-322338

Article  PubMed  Google Scholar 

Jiang H, He H, Chen Y, Huang W, Cheng J, Ye J, Wang A, Tao J, Wang C, Liu Q, Jin T, Jiang W, Deng X, Zhou R (2017) Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J Exp Med 214:3219–3238. https://doi.org/10.1084/jem.20171419

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin X, Liu M-Y, Zhang D-F, Zhong X, Du K, Qian P, Yao W-F, Gao H, Wei M-J (2019) Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4/NF-κB signaling pathway. CNS Neurosci Ther 25:575–590. https://doi.org/10.1111/cns.13086

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kalia SK, Sankar T, Lozano AM (2013) Deep brain stimulation for Parkinson’s disease and other movement disorders. Curr Opin Neurol 26:374–380. https://doi.org/10.1097/WCO.0b013e3283632d08

Article  PubMed  Google Scholar 

Kraus B, Wolff H, Heilmann J, Elstner EF (2007) Influence of Hypericum perforatum extract and its single compounds on amyloid-beta mediated toxicity in microglial cells. Life Sci 81:884–894. https://doi.org/10.1016/j.lfs.2007.07.020

Article  CAS  PubMed  Google Scholar 

Lawrence GMEP, Holley CL, Schroder K (2022) Parkinson’s disease: connecting mitochondria to inflammasomes. Trends Immunol 43:877–885. https://doi.org/10.1016/j.it.2022.09.010

Article  CAS  PubMed  Google Scholar 

Lei H, Ren R, Sun Y, Zhang K, Zhao X, Ablat N, Pu X (2020) Neuroprotective effects of safflower flavonoid extract in 6-hydroxydopamine-induced model of Parkinson’s disease may be related to its anti-inflammatory action. Mol Basel Switz 25:5206. https://doi.org/10.3390/molecules25215206

Article  CAS  Google Scholar 

Li Y, Song W, Tong Y, Zhang X, Zhao J, Gao X, Yong J, Wang H (2021) Isoliquiritin ameliorates depression by suppressing NLRP3-mediated pyroptosis via miRNA-27a/SYK/NF-κB axis. J Neuroinflammation 18:1. https://doi.org/10.1186/s12974-020-02040-8

Article  CAS  PubMed